Display options
Share it on

Toxicol Res. 2015 Mar;31(1):77-88. doi: 10.5487/TR.2015.31.1.077.

Single- and Repeat-dose Oral Toxicity Studies of Lithospermum erythrorhizon Extract in Dogs.

Toxicological research

Chunja Nam, Jae-Sik Hwang, Myoung-Jun Kim, Young Whan Choi, Kyoung-Goo Han, Jong-Koo Kang

Affiliations

  1. Biotoxtech Co., Ltd., Cheongju, Korea.
  2. Department of Horticultural Bioscience, Pusan National University, Miryang, Korea.
  3. Biotoxtech Co., Ltd., Cheongju, Korea ; Department of Laboratory Animal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea.

PMID: 25874036 PMCID: PMC4395658 DOI: 10.5487/TR.2015.31.1.077

Abstract

Lithospermum erythrorhizon has long been used in traditional Asian medicine for the treatment of diseases, including skin cancer. The oral toxicity of a hexane extract of Lithospermum erythrorhizon root (LEH) was investigated in Beagle dogs by using single escalating doses, two-week dose range-finding, and 4-week oral repeat dosing. In the single dose-escalating oral toxicity study, no animal died, showed adverse clinical signs, or changes in body weight gain at LEH doses of up to 2,000 mg/kg. In a 2 week dose range-finding study, no treatment-related adverse effects were detected by urinalysis, hematology, blood biochemistry, organ weights, or gross and histopathological examinations at doses of up to 500 mg LEH/kg/day. In the 4 week repeat-dose toxicity study, a weight loss or decreased weight gain was observed at 300 mg/kg/day. Although levels of serum triglyceride and total bilirubin were increased in a dose dependent manner, there were no related morphological changes. Based on these findings, the sub-acute no observable adverse effect level for 4-week oral administration of LEH in Beagles was 100 mg/kg/day.

Keywords: Beagle dogs; Lithospermum erythrorhizon extract; Sub-acute toxicity

References

  1. Yakugaku Zasshi. 2008 Nov;128(11):1681-8 - PubMed
  2. Int J Cancer. 2009 May 15;124(10):2450-9 - PubMed
  3. Can J Vet Res. 2011 Jan;75(1):42-8 - PubMed
  4. Cell Res. 2008 Aug;18(8):879-88 - PubMed
  5. Phytother Res. 2008 Mar;22(3):407-15 - PubMed
  6. Biol Pharm Bull. 2010;33(5):816-24 - PubMed
  7. Br J Pharmacol. 2010 Dec;161(7):1496-511 - PubMed
  8. J Ethnopharmacol. 2012 Nov 21;144(2):335-45 - PubMed
  9. Eur J Pharm Sci. 2013 Jul 16;49(4):637-41 - PubMed
  10. Ann Surg Oncol. 2012 Sep;19(9):3097-106 - PubMed
  11. Can J Physiol Pharmacol. 2010 Dec;88(12):1138-46 - PubMed
  12. Phytother Res. 2002 May;16(3):199-209 - PubMed

Publication Types